H Lundbeck A/S/ DK0061804770 /
9/10/2024 10:16:00 AM | Chg. +3.26 | Volume | Bid7/19/2024 | Ask10:16:00 AM | High | Low |
---|---|---|---|---|---|---|
46.74DKK | +7.50% | 1 Turnover: 46.74 |
-Bid Size: - | -Ask Size: - | 46.74 | 46.74 |
GlobeNewswire
8/5
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
5/1
Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer a...
GlobeNewswire
11/29/2023
Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Ch...
GlobeNewswire
3/28/2022
Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2021 and Business ...
GlobeNewswire
3/17/2022
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Finan...
GlobeNewswire
3/7/2022
EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officer
GlobeNewswire
2/24/2022
Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
GlobeNewswire
2/16/2022
Mental Health America Releases First-Ever Dashboard With Results of 2.6 Million Mental Health Screen...
GlobeNewswire
2/14/2022
Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer
GlobeNewswire
11/2/2021
Cellectar Appoints Laurence Reilly, M.D., LL.M Interim Chief Medical Officer
GlobeNewswire
10/13/2021
New Analysis Finds St. Louis County, Missouri Had Highest Percentage of Population Screen At-Risk fo...
GlobeNewswire
8/23/2021
Update -- Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors
GlobeNewswire
8/12/2021
Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors